Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis. [electronic resource]
Producer: 20191025Description: 102-109 p. digitalISSN:- 1878-1780
- Adult
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination -- adverse effects
- Female
- Glucagon-Like Peptide-1 Receptor -- antagonists & inhibitors
- Glucagon-Like Peptides -- administration & dosage
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- administration & dosage
- Incretins -- administration & dosage
- Male
- Middle Aged
- Randomized Controlled Trials as Topic -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.